JP6238991B2 - 局所ケトプロフェン組成物 - Google Patents

局所ケトプロフェン組成物 Download PDF

Info

Publication number
JP6238991B2
JP6238991B2 JP2015534599A JP2015534599A JP6238991B2 JP 6238991 B2 JP6238991 B2 JP 6238991B2 JP 2015534599 A JP2015534599 A JP 2015534599A JP 2015534599 A JP2015534599 A JP 2015534599A JP 6238991 B2 JP6238991 B2 JP 6238991B2
Authority
JP
Japan
Prior art keywords
percent
ketoprofen
composition
polyacrylic acid
topical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015534599A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015531374A (ja
JP2015531374A5 (enExample
Inventor
ブユックティムキン，セルベット
ブユックティムキン，ナーディル
イェーガー，ジェームズ・エル
Original Assignee
アケリオス セラピューティクス，インコーポレーテッド
アケリオス セラピューティクス，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アケリオス セラピューティクス，インコーポレーテッド, アケリオス セラピューティクス，インコーポレーテッド filed Critical アケリオス セラピューティクス，インコーポレーテッド
Publication of JP2015531374A publication Critical patent/JP2015531374A/ja
Publication of JP2015531374A5 publication Critical patent/JP2015531374A5/ja
Application granted granted Critical
Publication of JP6238991B2 publication Critical patent/JP6238991B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2015534599A 2012-09-27 2013-09-24 局所ケトプロフェン組成物 Expired - Fee Related JP6238991B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261706163P 2012-09-27 2012-09-27
US61/706,163 2012-09-27
US13/826,706 US8822537B2 (en) 2012-09-27 2013-03-14 Topical ketoprofen composition
US13/826,706 2013-03-14
PCT/US2013/061403 WO2014052313A1 (en) 2012-09-27 2013-09-24 Topical ketoprofen composition

Publications (3)

Publication Number Publication Date
JP2015531374A JP2015531374A (ja) 2015-11-02
JP2015531374A5 JP2015531374A5 (enExample) 2016-12-28
JP6238991B2 true JP6238991B2 (ja) 2017-11-29

Family

ID=50339476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015534599A Expired - Fee Related JP6238991B2 (ja) 2012-09-27 2013-09-24 局所ケトプロフェン組成物

Country Status (13)

Country Link
US (1) US8822537B2 (enExample)
EP (1) EP2900231B1 (enExample)
JP (1) JP6238991B2 (enExample)
KR (1) KR102184245B1 (enExample)
AU (1) AU2013323766B2 (enExample)
BR (1) BR112015006790B1 (enExample)
CA (1) CA2885619C (enExample)
ES (1) ES2902850T3 (enExample)
IL (1) IL237810B (enExample)
MX (1) MX373916B (enExample)
NZ (1) NZ706108A (enExample)
RU (1) RU2652345C2 (enExample)
WO (1) WO2014052313A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006073A1 (en) 2009-07-10 2011-01-13 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
CN107614061A (zh) * 2014-12-01 2018-01-19 阿科莱尔斯疗法公司 用于治疗与疼痛有关的偏头痛和病症方法和组合物
US11021443B2 (en) 2015-08-03 2021-06-01 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
CA3045004A1 (en) * 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
JP2019510824A (ja) * 2016-03-31 2019-04-18 スマーテック・トピカル・インコーポレイテッドＳＭＡＲＴＥＣＨ ＴＯＰＩＣＡＬ，Ｉｎｃ． 送達システム
WO2019105957A1 (en) * 2017-11-30 2019-06-06 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Stable liquid composition of ketoprofen, salts and enantiomers thereof
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
WO2020227646A1 (en) 2019-05-09 2020-11-12 Apkarian Technologies Llc Methods and compositions for treating pain
AU2020380118B2 (en) 2019-11-06 2026-06-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
MX2022005168A (es) * 2019-11-06 2022-06-08 Smartech Topical Inc Formulaciones topicas de inhibidores de la ciclooxigenasa y su uso.
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
US5863527A (en) * 1996-09-04 1999-01-26 The Proctor & Gamble Company Personal care compositions
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
US6613341B2 (en) * 2001-05-30 2003-09-02 The Procter & Gamble Company Topical composition comprising a substituted cosmetic bonding agent
DE10141258B4 (de) * 2001-08-23 2004-09-23 Beiersdorf Ag Kosmetische und dermatologische Zubereitung und ihre Verwendung
US7235230B2 (en) * 2001-10-24 2007-06-26 Clariant Finance (Bvi) Limited Leave-on compositions for personal care
ITFI20030070A1 (it) * 2003-03-18 2004-09-19 Berlin Chemie Ag Formulazioni topiche stabilizzate contenenti ketoprofene
EP1488787A1 (en) 2003-06-20 2004-12-22 Berlin-Chemie Ag Topical stabilized formulations containing ketoprofen
CA2538856C (en) * 2003-10-10 2010-06-29 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
JP4990617B2 (ja) * 2004-06-15 2012-08-01 久光製薬株式会社 消炎鎮痛外用剤
PT1872796E (pt) * 2005-02-25 2011-11-03 Hisamitsu Pharmaceutical Co Preparação transdérmica para uso externo contendo um agente anti-inflamatório/analgésico não esteróide
EP1924254A4 (en) * 2005-09-15 2011-01-19 Biomas Ltd USE OF TELLURO COMPOUNDS FOR PROTECTION AGAINST ULTRAVIOLET RADIATION
CN101426468B (zh) * 2006-04-18 2012-02-08 帝斯曼知识产权资产管理有限公司 包含水杨酸和抗坏血酸的化妆品组合物
WO2009139817A2 (en) * 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US8409600B2 (en) * 2009-01-23 2013-04-02 J&E Solutions, Llc Methods for prevention and/or treatment of capsular contracture
JP6200648B2 (ja) * 2009-12-18 2017-09-20 アケリオス セラピューティクス，インコーポレーテッド 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物

Also Published As

Publication number Publication date
MX373916B (es) 2020-07-10
RU2652345C2 (ru) 2018-04-25
BR112015006790B1 (pt) 2022-05-31
WO2014052313A1 (en) 2014-04-03
JP2015531374A (ja) 2015-11-02
EP2900231B1 (en) 2021-11-03
AU2013323766B2 (en) 2017-08-17
AU2013323766A1 (en) 2015-04-09
MX2015004006A (es) 2015-10-29
US20140088195A1 (en) 2014-03-27
IL237810B (en) 2018-06-28
KR20150074009A (ko) 2015-07-01
CA2885619C (en) 2020-09-08
RU2015115723A (ru) 2016-11-20
CA2885619A1 (en) 2014-04-03
EP2900231A4 (en) 2016-03-02
US8822537B2 (en) 2014-09-02
NZ706108A (en) 2018-03-23
ES2902850T3 (es) 2022-03-30
KR102184245B1 (ko) 2020-11-30
BR112015006790A2 (pt) 2017-07-04
EP2900231A1 (en) 2015-08-05
HK1212898A1 (en) 2016-06-24

Similar Documents

Publication Publication Date Title
CA2885619C (en) Topical ketoprofen composition
JP2015531374A5 (enExample)
US10085939B2 (en) Composition of dexibuprofen transdermal hydrogel
AU2003264086B2 (en) Topical emulsion- gel composition comprising diclofenac sodium
CN1469748A (zh) 用于局部传送环加氧酶-2酶抑制剂的药物组合物
US20060241175A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
JP4195178B2 (ja) 消炎鎮痛外用剤
JP2024163305A (ja) ロキソプロフェン及び可溶化剤を含有する皮膚外用剤
CN1909929B (zh) 消炎镇痛外用药
JP2012092067A (ja) 非ステロイド性消炎鎮痛外用剤
Doppalapudi et al. Fenoldopam mesylate for treating psoriasis: A new indication for an old drug
JP4807721B2 (ja) 消炎鎮痛外用剤
KR101894891B1 (ko) 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형
JP7586879B2 (ja) 医薬組成物
JP7550014B2 (ja) 医薬組成物
HK1212898B (en) Topical ketoprofen composition
JP2005145932A (ja) 消炎鎮痛外用剤
JP2004123632A (ja) 消炎鎮痛外用剤
JP2018108954A (ja) 医薬組成物
JP2005213192A (ja) 消炎鎮痛外用剤
JP2024519493A (ja) 局所ナプロキセン製剤及びそれらの使用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160913

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170919

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20171003

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20171031

R150 Certificate of patent or registration of utility model

Ref document number: 6238991

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees